HKSE - Delayed Quote HKD
Shanghai Henlius Biotech, Inc. (2696.HK)
36.600
+2.350
+(6.86%)
At close: May 13 at 4:08:31 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
1,241,887
1,241,887
1,047,921
981,620
90,392
Investing Cash Flow
-909,965
-909,965
-1,004,437
-1,358,731
-1,681,254
Financing Cash Flow
-643,367
-643,367
144,431
858,016
648,302
End Cash Position
571,401
571,401
867,663
673,476
154,982
Capital Expenditure
-837,206
-837,206
-1,011,444
-1,365,292
-1,131,193
Issuance of Capital Stock
2,949,753
--
--
--
--
Issuance of Debt
2,673,958
2,673,958
2,511,759
2,859,028
2,095,706
Repayment of Debt
-3,081,685
-3,081,685
-2,147,093
-1,785,465
-1,295,651
Free Cash Flow
404,681
404,681
36,477
-383,672
-1,040,801
12/31/2021 - 9/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2410.HK TYK Medicines, Inc
30.450
-3.94%
2509.HK Qyuns Therapeutics Co., Ltd.
11.220
+1.63%
1477.HK OCUMENSION-B
5.210
+0.19%
2256.HK Abbisko Cayman Limited
8.060
+10.41%
9969.HK InnoCare Pharma Limited
9.500
-0.21%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
315.000
+2.67%
2105.HK Laekna, Inc.
14.420
+4.95%
1877.HK JUNSHI BIO
14.120
-2.62%
3759.HK Pharmaron Beijing Co., Ltd.
13.620
-1.45%
1530.HK 3SBIO
11.500
+2.50%